Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01090362 · ClinicalTrials.gov registry record
Global Anticoagulant Registry in the Field
A clinical trial, sponsored by Thrombosis Research Institute.
- Completed
- Registry status
- 57,250
- Enrollment target
NCT01090362: Completed study, sponsored by Thrombosis Research Institute.
NCT01090362 is a clinical trial that has completed, run by Thrombosis Research Institute. The registered enrollment target is 57,250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01090362 has completed, sponsored by Thrombosis Research Institute.
- COMPLETED
- Registry status
- 57,250 participants
- Enrollment target
Study Summary
The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF Registry) is a non-interventional, observational study that characterized a global population of non-valvular atrial fibrillation patients. The registry was used to document global baseline characteristics, current treatment strategies and outcome measures. Characterisation of a number of AF sub-populations was also completed. GARFIELD-AF is an independent academic research initiative sponsored by the Thrombosis Research Institute (London, UK) and supported by an unrestricted research grant from Bayer AG (Berlin, Germany).
Primary Outcome
All cause mortality including cardiovascular and non-cardiovascular death
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57,250 participants |
| Start Date | 2009-12-21 |
| Est. Completion | 2020-05-18 |
What the finished NCT01090362 record still lists
NCT01090362 is an observational study that tracks outcomes without assigning an intervention. Its 57,250 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01090362 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01090362 about?
NCT01090362 is a clinical study titled "Global Anticoagulant Registry in the Field". The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF Registry) is a non-interventional, observational study that characterized a global population of non-valvular atrial fibrillation patients. The registry was used to document global baseline characteristics, current treat...
What is the current status of trial NCT01090362?
This trial is currently completed. The enrollment target is 57,250 participants. The study started on 2009-12-21. Estimated completion is 2020-05-18.
Who is sponsoring clinical trial NCT01090362?
This trial is sponsored by Thrombosis Research Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00785525 · 60,000 participants · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
- NCT01825499 · 60,000 participants
Vermont Oxford Network Very Low Birth Weight Database
- NCT02850588 · 60,000 participants
SVS VQI TransCarotid Revascularization Surveillance Project
- NCT03752840 · 60,200 participants · NA
Village-Integrated Eye Worker Trial II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI